• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 10, 2024 at 11:32: AM
via Amylyx Pharmaceuticals is looking to rebuild its pipeline after dropping Relyvrio and acquiring a Phase III ready glucagon-like peptide 1 receptor antagonist (GLP1-RA), avexitide, from bankrupt Eiger BioPharmaceuticals in a $35.1m deal.

article source
 

<



Similar threads

cafead
Amylyx Rebuilds Momentum Following Relyvrio Market Withdrawal
Replies
0
Views
10
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Amylyx Purchases Investigational GLP-1 Drug Avexitide in Auction Deal for $35 Million
Replies
0
Views
36
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio?
Replies
0
Views
62
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Amylyx to pull ALS drug Relyvrio From US, Canada markets after phase III fail
Replies
0
Views
160
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
After trial failure, will Amylyx pull ALS drug Relyvrio off the market?
Replies
0
Views
86
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote